MicroRNAs accurately identify cancer tissue origin

MicroRNAs (miRNAs) belong to a class of noncoding, regulatory RNAs that is involved in oncogenesis and shows remarkable tissue specificity. Their potential for tumor classification suggests they may be used in identifying the tissue in which cancers of unknown primary origin arose, a major clinical problem. We measured miRNA expression levels in 400 paraffin-embedded and fresh-frozen samples from 22 different tumor tissues and metastases. We used miRNA microarray data of 253 samples to construct a transparent classifier based on 48 miRNAs. Two-thirds of samples were classified with high confidence, with accuracy >90%. In an independent blinded test-set of 83 samples, overall high-confidence accuracy reached 89%. Classification accuracy reached 100% for most tissue classes, including 131 metastatic samples. We further validated the utility of the miRNA biomarkers by quantitative RT-PCR using 65 additional blinded test samples. Our findings demonstrate the effectiveness of miRNAs as biomarkers for tracing the tissue of origin of cancers of unknown primary origin.

[1]  T. Poggio,et al.  Multiclass cancer diagnosis using tumor gene expression signatures , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[3]  A. Hartmann,et al.  Cancer of unknown primary: clinicopathologic correlations , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[4]  A. Folpe,et al.  Potential Utility of Uroplakin III, Thrombomodulin, High Molecular Weight Cytokeratin, and Cytokeratin 20 in Noninvasive, Invasive, and Metastatic Urothelial (Transitional Cell) Carcinomas , 2003, The American journal of surgical pathology.

[5]  Sharon L R Kardia,et al.  Accurate molecular classification of human cancers based on gene expression using a simple classifier with a pathological tree-based framework. , 2003, The American journal of pathology.

[6]  V. Ambros,et al.  Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.

[7]  C. Perou,et al.  A custom microarray platform for analysis of microRNA gene expression , 2004, Nature Methods.

[8]  I. Yang,et al.  Multi-platform, multi-site, microarray-based human tumor classification. , 2004, The American journal of pathology.

[9]  R. Lenzi,et al.  Diagnostic strategies for unknown primary cancer , 2004, Cancer.

[10]  T. K. Marshall,et al.  CLINICOPATHOLOGIC CORRELATIONS , 2005 .

[11]  Michael T. McManus,et al.  The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development , 2005, Nature.

[12]  Adam Kowalczyk,et al.  An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. , 2005, Cancer research.

[13]  Kwang-Soo Kim,et al.  Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down-regulation of Putative Targets during Differentiation* , 2005, Journal of Biological Chemistry.

[14]  Eytan Domany,et al.  Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.

[15]  D. Bartel,et al.  Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. , 2005, RNA.

[16]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[17]  C. Burge,et al.  The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.

[18]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[19]  Rui Shi,et al.  Facile means for quantifying microRNA expression by real-time PCR. , 2005, BioTechniques.

[20]  R. Aharonov,et al.  Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.

[21]  M. Cronin,et al.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  David C. Atkins,et al.  A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. , 2006, The Journal of molecular diagnostics : JMD.

[24]  Joel S Parker,et al.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.

[25]  R. Salunga,et al.  Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. , 2009, Archives of pathology & laboratory medicine.

[26]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[27]  W. Hop,et al.  High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas , 2007, Cytogenetic and Genome Research.

[28]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[29]  Kimihiro Hino,et al.  Regulatory Interaction of HNF1α to microRNA194 Gene During Intestinal Epithelial Cell Differentiation , 2007 .

[30]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[31]  Moshe Oren,et al.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. , 2007, Molecular cell.

[32]  J. Pimiento,et al.  Cancer of unknown primary origin: a decade of experience in a community-based hospital. , 2007, American journal of surgery.

[33]  T. Crosby,et al.  A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).